The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

Little by little, the costs of U.S. President Donald Trump's tariffs are starting to add up, both for consumers and American companies that are raising prices, reporting tariff-related hits to their profits,

Donald Trump is winning the tariff war — sort of. Last spring, new Canadian prime minister and former central banker (and Goldman Sachs alum) Mark Carney declared that nearly a century of American-led global economic order was coming to an end.